Technologies

IDMIT benefits from considerable expertise and skills in viral pathogenesis, chemo-prophylaxis (microbicides, pre- and post-exposure prophylaxis) and vaccines using NHP models of human infections, in particular through its contribution to the development of the NHP models of human HIV infection and AIDS.

IDMIT partners, all international leaders in the field of research into host-pathogen interactions, provide complementary expertise with outstanding platforms for monitoring diseases, treatments and prevention in relevant animal models of human infections.

Highly innovative technologies, such as multiparametric cell phenotyping, mass cytometry and in vivo imaging of the immune system and pathogens, are developed, building on the expertise of the founder members in infectious disease models. IDMIT also beneficits of the existing facilities on the CEA-Fontenay-aux-Roses site and the know-how of the Molecular Imaging Research Center (MIRCen).

Together, six different and complementary technological laboratories constitute the core facilities of IDMIT.

Four are under the responsability of the CEA (coordinator: Dr. Bosquet N.):

  • “Immunology & infectiology”,
  • “FlowCyTech”,
  • “Infection & Immunity imaging”,
  • “Animal science”.

The two last are managed by BertinPharma, our private co-founder partner:

  • “Biological Resource Center”
  • “PharmImmune”